Previous 10 | Next 10 |
2024-03-20 07:36:45 ET More on ImmunoPrecise IPA stock rallies 30% on new AI model for drug discovery Seeking Alpha’s Quant Rating on ImmunoPrecise Historical earnings data for ImmunoPrecise Financial information for ImmunoPrecise Read the fu...
Significant throughput of LSA to advance IPA’s diversity- and data-driven drug development and to enrich LENS ai™ . IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an artificial intelligence-driven biotherapeuti...
2024-03-14 14:49:13 ET ImmunoPrecise Antibodies Ltd. (IPA) Q3 2024 Earnings Conference Call March 14, 2024 10:30 AM ET Company Participants Jennifer Bath - Chief Executive Officer and President Kristin Taylor - Chief Financial Officer Conference Call Participan...
2024-03-14 08:09:29 ET More on ImmunoPrecise IPA stock rallies 30% on new AI model for drug discovery Seeking Alpha’s Quant Rating on ImmunoPrecise Historical earnings data for ImmunoPrecise Financial information for ImmunoPrecise Read the fu...
IPA reports a fourth consecutive quarter of increased revenue. IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an artificial intelligence-driven biotherapeutic research and technology company, today reported financial results for i...
AIA Group Limited ADR (AAGIY) is expected to report for Q4 2023 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 SecureWorks Corp. (SCWX) is expected to report $-0.15 for Q4 2024 Acacia Research Corporation (ACTG) is expected to report for quarter end...
2024-03-08 08:40:50 ET Losers: Amylyx Pharmaceuticals ( AMLX ) -81% as late-stage ALS trial for Relyvrio fails . BigBear.ai Holdings BBAI -20% after Q4 earnings release . AerSale Corp ASLE -20% after Q4 earnings release . OppFi OPFI -17% aft...
VICTORIA, BC / ACCESSWIRE / March 8, 2024 / Anyone familiar with the intricacies of life science knows how truly complicated DNA is; without a full understanding of the language of DNA, scientists are often at a standstill when it comes to advanced medicine. That's why the work of companies like...
2024-03-07 10:01:04 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Waters, Moderna most shorted ...
2024-03-07 09:41:59 ET More on ImmunoPrecise ImmunoPrecise Antibodies Ltd. (IPA) Q2 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on ImmunoPrecise Historical earnings data for ImmunoPrecise Financial information for ImmunoPrecise ...
News, Short Squeeze, Breakout and More Instantly...
ImmunoPrecise Antibodies Ltd. Company Name:
IPA Stock Symbol:
NASDAQ Market:
ImmunoPrecise Antibodies Ltd. Website:
The Company to host an earnings conference call via webcast ImmunoPrecise Antibodies Ltd. (the "Company" or "IPA") (NASDAQ: IPA) today announces the rescheduling of its full year fiscal 2024 financial results and business highlights release. Originally set for July 25, 2024, the new rel...
ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, today announced that it has entered into a securities purchase agreement (the “Securities Purchase Agreement”) with YA II ...
The Company to host an earnings conference call via webcast IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, will announce its full year fiscal 2024 financial results and ...